|
gptkbp:instanceOf
|
gptkb:investor
|
|
gptkbp:assetsUnderManagement
|
over $9 billion
|
|
gptkbp:focusesOn
|
gptkb:biotechnology
life sciences
early-stage technology companies
|
|
gptkbp:foundedIn
|
1986
|
|
gptkbp:founder
|
gptkb:Robert_Nelsen
gptkb:Clinton_Bybee
gptkb:Steven_Lazarus
gptkb:Keith_Crandell
|
|
gptkbp:headquartersLocation
|
gptkb:Chicago,_Illinois,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
ARCH Venture Partners
|
|
gptkbp:industry
|
venture capital
|
|
gptkbp:investedIn
|
startups spun out of academic research
|
|
gptkbp:notableExit
|
gptkb:10x_Genomics_IPO
gptkb:Agios_Pharmaceuticals_IPO
gptkb:Beam_Therapeutics_IPO
gptkb:Denali_Therapeutics_IPO
gptkb:Grail_acquisition_by_Illumina
gptkb:Illumina_IPO
gptkb:Juno_Therapeutics_acquisition_by_Celgene
gptkb:Prime_Medicine_IPO
gptkb:Rubius_Therapeutics_IPO
gptkb:Twist_Bioscience_IPO
gptkb:Unity_Biotechnology_IPO
gptkb:Vir_Biotechnology_IPO
gptkb:Alnylam_Pharmaceuticals_IPO
gptkb:Editas_Medicine_IPO
Relay Therapeutics IPO
Sage Therapeutics IPO
|
|
gptkbp:notableInvestment
|
gptkb:Unity_Biotechnology
gptkb:Alnylam_Pharmaceuticals
gptkb:Illumina
gptkb:Twist_Bioscience
gptkb:Grail
gptkb:Beam_Therapeutics
gptkb:Juno_Therapeutics
gptkb:Sage_Therapeutics
|
|
gptkbp:officeLocation
|
gptkb:Boston,_Massachusetts,_United_States
gptkb:Dublin,_Ireland
gptkb:San_Francisco,_California,_United_States
gptkb:Seattle,_Washington,_United_States
|
|
gptkbp:partner
|
gptkb:Robert_Nelsen
gptkb:Clinton_Bybee
gptkb:Paul_Thurk
gptkb:Tom_Daniel
gptkb:Vikram_Bajaj
gptkb:Stephen_Elledge
gptkb:Emily_Leproust
gptkb:Keith_Crandell
gptkb:Kristina_Burow
|
|
gptkbp:website
|
https://www.archventure.com/
|
|
gptkbp:bfsParent
|
gptkb:Beam_Therapeutics
gptkb:KSQ_Therapeutics
gptkb:Sana_Biotechnology
|
|
gptkbp:bfsLayer
|
5
|